Bulletin
Investor Alert

New York Markets Open in:

Cyclo Therapeutics Inc.

NAS: CYTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jan 31, 2023, 7:35 p.m.

/zigman2/quotes/207006339/composite

$

1.76

Change

0.00 0.00%

Volume

Volume 105

Quotes are delayed by 20 min

/zigman2/quotes/207006339/composite

Previous close

$ 1.68

$ 1.76

Change

+0.08 +4.76%

Day low

Day high

$1.65

$1.93

Open

52 week low

52 week high

$0.91

$4.04

Open

Annual Financials for Cyclo Therapeutics Inc.

Fiscal year is January-December. All values USD millions. 20172018201920202021 5-year trend
Sales/Revenue 1.24M1.01M1.01M903,3761.59M
Cost of Goods Sold (COGS) incl. D&A 1.33M1.29M1.99M2.64M4.01M
COGS excluding D&A 1.32M1.28M1.98M2.63M3.99M
Depreciation & Amortization Expense 9,27110,1245,68112,76316,827
Depreciation 9,27110,1245,68112,76316,827
Amortization of Intangibles -----
Gross Income (87,874)(275,614)(980,414)(1.74M)(2.43M)
20172018201920202021 5-year trend
SG&A Expense 3.75M3.98M6.41M7.22M11.86M
Research & Development 2.29M2.71M4.87M6.1M9.15M
Other SG&A 1.46M1.27M1.54M1.13M-
Other Operating Expense 5,50012,150153,770--
Unusual Expense -----
EBIT after Unusual Expense -----
Non Operating Income/Expense 2,820----
Non-Operating Interest Income 10,26111,77312,02719,8023,405
Equity in Affiliates (Pretax) -----
Interest Expense -----
Gross Interest Expense -----
Interest Capitalized -----
Pretax Income (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
Income Tax -----
Income Tax - Current Domestic -----
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic -----
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
Minority Interest Expense -----
Net Income (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
Preferred Dividends -----
Net Income Available to Common (3.83M)(4.26M)(7.53M)(8.94M)(14.29M)
EPS (Basic) (5.00)(0.05)(6.96)(5.59)(2.24)
Basic Shares Outstanding 720,37281.76M1.08M1.6M6.37M
EPS (Diluted) (5.00)(0.05)(6.96)(5.59)(2.24)
Diluted Shares Outstanding 720,37281.76M1.08M1.6M6.37M
EBITDA (3.84M)(4.26M)(7.54M)(8.95M)(14.27M)
Link to MarketWatch's Slice.